These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19581812)

  • 1. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
    Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C
    J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].
    Van Beers B
    Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.
    Wong GL; Wong VW; Choi PC; Chan AW; Chum RH; Chan HK; Lau KK; Chim AM; Yiu KK; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1027-35. PubMed ID: 18456573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Ikegami T; Yamashita Y; Itoh S; Kuroda Y; Maehara Y
    Transplantation; 2008 Jan; 85(1):69-74. PubMed ID: 18192914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.
    Cassinotto C; Lapuyade B; Aït-Ali A; Vergniol J; Gaye D; Foucher J; Bailacq-Auder C; Chermak F; Le Bail B; de Lédinghen V
    Radiology; 2013 Oct; 269(1):283-92. PubMed ID: 23630312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.
    Salles N; Dussarat P; Foucher J; Villars S; de Lédinghen V
    Gastroenterol Clin Biol; 2009 Feb; 33(2):126-32. PubMed ID: 19193508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging.
    Mitchell DG; Navarro VJ; Herrine SK; Bergin D; Parker L; Frangos A; McCue P; Rubin R
    Abdom Imaging; 2008; 33(1):58-64. PubMed ID: 17387539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients.
    Kamphues C; Lotz K; Röcken C; Berg T; Eurich D; Pratschke J; Neuhaus P; Neumann UP
    Clin Transplant; 2010; 24(5):652-9. PubMed ID: 19925459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
    Corpechot C; El Naggar A; Poujol-Robert A; Ziol M; Wendum D; Chazouillères O; de Lédinghen V; Dhumeaux D; Marcellin P; Beaugrand M; Poupon R
    Hepatology; 2006 May; 43(5):1118-24. PubMed ID: 16628644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.
    Sasso M; Tengher-Barna I; Ziol M; Miette V; Fournier C; Sandrin L; Poupon R; Cardoso AC; Marcellin P; Douvin C; de Ledinghen V; Trinchet JC; Beaugrand M
    J Viral Hepat; 2012 Apr; 19(4):244-53. PubMed ID: 22404722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.